Description: Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Home Page: www.genommalab.com
Av. Antonio Dovalí Jaime no.70
Mexico City,
DF
01210
Mexico
Phone:
52 55 5081 0000
Officers
| Name | Title |
|---|---|
| Mr. Jorge Luis Brake Valderrama | Chief Exec. Officer |
| Engineer Antonio Zamora Galland | Exec. VP of Fin. & Admin. and CFO |
| Mr. Juan Marco Sparvieri | Exec. VP & COO |
| Daniel Suarez Neria | Head of Investor Relations |
| Lic. Ruben Alberto Luna Porres | Legal Officer |
| Marianne Blancas Velasco | Global Director of HR |
| Mr. Alejandro Bastón Patiño | Exec. VP of Institutional Relations, Media, HR & Sustainability |
| Mr. Efraín Tapia Córdova | Deputy Sec. |
| Mr. Máximo Juda | Advisor |
Exchange: MX
Country: MX
Currency: Mexican Peso (₱)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 7.6864 |
|---|---|
| Trailing PE: | 13.3769 |
| Price-to-Book MRQ: | 1.511 |
| Price-to-Sales TTM: | 1.0508 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2297 |